Antidepressant prescription for depression in general practice in the Netherlands

Pharmacy World and Science

Volumn 23, Issue 2, 2001, Pages 46-49

  Van Marwijk, Harm W J ^a   Bijl, Dick ^a   Adèr, Herman J ^a   De Haan, Marten ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Aantidepressant drugs; Consultations; Depression; General practice; Prescriptions

Indexed keywords

FLUOXETINE; MIRTAZAPINE; PAROXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CONSULTATION; DEPRESSION; GENERAL PRACTICE; HUMAN; MORBIDITY; NETHERLANDS; PRACTICE GUIDELINE; PRESCRIPTION;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG UTILIZATION; FAMILY PRACTICE; HUMANS; NETHERLANDS; PRESCRIPTIONS, DRUG;

EID: 0035010176     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011294305606     Document Type: Article

References (22)

1. Dutch College of General Practitioners guidelines on depression
2. Consensus on depression in adults
3. Antidepressants: Is new better?
4. SSRIs versus other antidepressants for depressive disorder (Cochrane Review)
5. A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary
6. Prescription of antidepressants in family practice
7. Prescribing antidepressants in general practice
8. Antidepressant drug choice for first users in two regions in the Netherlands
9. Complementary audit data
10. Treatment of depression and comorbid anxiety
11. Depression diagnoses and antidepressant use in primary care practices: A study from the Practice Partner Research Network (PPRNet)
12. North of England evidence-based guideline development project: Summary version of guidelines for the choice of antidepressants for depression in primary care
13. The treatment of depression in UK general practice: Selective serotonin reuptake inhibitors and tricyclic antidepressants compared
14. Antidepressant treatment in general practice-an interview study
15. A comparison of drugs versus placebo for the treatment of dysthymia (Cochrane Review)
16. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis